Peter Spargo

Dr. Spargo has served as the Senior Vice President, of Chemistry Manufacturing and Controls (CMC) since May 2014.

From January to October 2015, Dr. Spargo also served as Senior Vice President, CMC at Spinifex Pharmaceuticals, a biotechnology company that was acquired by Novartis International. From 2011 to 2013, Dr. Spargo was Senior Vice President, CMC at Creabilis, a pharmaceutical company. Dr. Spargo received a Ph.D. in synthetic organic chemistry from Cambridge University.